Online Courses

This session will help the learner to identify the barriers and challenges and solutions to these regarding implementation of pharmacogenomic services in institutional settings. During this session, the learner will develop a greater awareness and understanding of the necessary phases of implementation of PGx services. In addition, various avenues for reimbursement for pharmacogenomic testing will be discussed to give the learner greater confidence of when to recommend pharmacogenomic testing. G...

This self-study session will review the current landscape of pharmacogenomics and describe barriers to successful implementation of pharmacogenomics in clinic. Participants will learn to recognize referral indications and clinical scenarios that may be informed by pharmacogenomic testing, as well as understand the potential barriers to pharmacogenomic testing at the patient and provider level. Specific issues and concerns related to the use of race, ethnicity, and ancestry data in pharmacogenomi...

This self-study session will highlight the impact of major genetic variants in the HLA complex on drug-induced hypersensitivity reactions involving neurologic agents (phenytoin, carbamazepine, and oxcarbazepine), allopurinol and abacavir. During this session, the learner will develop greater awareness of what PGx guideline resources to use to formulate therapeutic recommendations based on available patient pharmacogenomic data involving these medications. Importantly, this session will also prov...

This self-study activity will provide the foundation for discussion of pharmacogenomics of germline and somatic oncology during the live activity.

This self-study session will highlight the impact of major genetic variants in antidepressant metabolism and pharmacodynamics on treatment response. During this session, the learner will develop greater awareness of what PGx guideline resources to use to formulate therapeutic recommendations based on available patient pharmacogenomic data. This session will include a summary of main findings from the literature supporting payor coverage for PGx-guided treatment of depression. Finally, this sessi...

This self-study session will highlight the impact of major genetic variations associated with the clinical effect and safety of opioids and non-steroidal anti-inflammatory drugs. During this session, the learner will develop greater awareness of which clinical guideline resources to use when formulating therapeutic recommendations based on available patient pharmacogenomic data. This session will include a summary of evidence-based findings from the literature supporting individual genes that ar...

This self-study session will provide an overview of the clinical application and implementation of pharmacogenomics in cardiology, specifically focusing on pharmacogenomic-guided antiplatelet and anticoagulant therapy. The learner will be oriented to the clinically relevant drug-gene pairs and the interpretation of such results. This session will also highlight literature, FDA labeling, and practice guidelines supporting the use of pharmacogenomics. Integrated case examples will help the learner...

This self-study session is designed to be completed during week 1 of the Interprofessional Clinical Pharmacogenomics Certificate program. This activity will describe the fundamentals of pharmacogenomics and provide the learner with knowledge of how to use evidence-based pharmacogenomic database resources. In addition, this session will highlight major genetic variants associated with drug metabolism and the impact of these on pharmacokinetic parameters and drug response. Important principles of ...